EUVIMEDEUVIMED entdecken
Crossref

Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis

Shariqa Jan, Kaneez Fatima, Sameer Ullah Khan, Fayaz A Malik

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-12200-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 09.07.2026. Verfasst von Shariqa Jan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Srinagar-190005, Jammu, Srinagar, Kashmir, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tankyrases, beta Catenin, Neoplasm Proteins. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsTankyrasesbeta CateninNeoplasm ProteinsATP Binding Cassette Transporter, Subfamily G, Member 2Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsHumansFemaleDrug Resistance, NeoplasmCisplatinMDA-MB-231 CellsCell Line, TumorAnimalsGene Expression Regulation, NeoplasticHeterocyclic Compounds, 3-RingMiceCell SurvivalSignal TransductionAntineoplastic Agents

Stichwörter der Autor:innen

ChemoresistanceDrug effluxPARsylationTNBCTankyrase

Substanzen

Tankyrasesbeta CateninCisplatinNeoplasm ProteinsATP Binding Cassette Transporter, Subfamily G, Member 2ABCG2 protein, humanXAV939Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsHeterocyclic Compounds, 3-RingTNKS protein, human

Autor:innen und Institutionen

  • Division of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Srinagar-190005, Jammu, Srinagar, Kashmir, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Pediatric oncology, Oregon Health & Science University Hospital, 3181 SW Sam Jackson Park Rd, OR, 97239, Portland, USA.
  • Division of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Srinagar-190005, Jammu, Srinagar, Kashmir, India. fmalik@iiim.ac.in.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. fmalik@iiim.ac.in.

Zitieren

APA

Jan, S., Fatima, K., Khan, S. U., & Malik, F. A. (2026). Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12200-3

Vancouver

Jan S, Fatima K, Khan SU, Malik FA. Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12200-3

BibTeX
@article{Jan2026,
  author = {Jan, Shariqa and Fatima, Kaneez and Khan, Sameer Ullah and Malik, Fayaz A},
  title = {Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-12200-3}
}
Kostenlos starten →